Clinical Trials Logo

Clinical Trial Summary

TMS has been safely and reliably delivered at the Harquail Centre for over 5 years, with a primary focus on conventional rTMS protocols for treatment-resistant depression. Recently, the investgator team has gained the capability to deliver sham-controlled intermittent theta-burst stimulation (iTBS) rTMS. Unlike conventional high frequency rTMS, which was used in the previous sham-controlled rTMS PCS pilot study, iTBS is a patterned form of stimulation that recapitulates endogenous activity patterns of neural circuits pairing gamma frequency (50Hz) burst pulses coupled in a theta frequency rhythm (5Hz).12 iTBS delivers 600 pulses in just over 3 minutes with similar or greater effects on neural plasticity compared to conventional rTMS (taking over 30-45 minutes) and similar tolerability and efficacy in trials of depression. Furthermore, novel accelerated iTBS protocols stimulating the left dorsolateral prefrontal cortex (dlPFC) over 8-10 treatments, 50 minutes apart over a 5 day interval has recently demonstrated robust efficacy in depression and received recent FDA approval. Thus, accelerated iTBS can be delivered in a single week of treatment compared to 6 weeks with conventional rTMS methods. Finally, the investigators recently acquired the technology to integrate MRI neuroimage-guided stimulation, which would allow to target specific brain regions/networks implicated in PCS at high spatial resolution. No studies to date have investigated image-guided accelerated iTBS rTMS for the treatment of PCS.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06031662
Study type Interventional
Source Sunnybrook Health Sciences Centre
Contact Sean Nestor, PhD, MD, FRCPC
Phone 416-480-4085
Email sean.nestor@sunnybrook.ca
Status Recruiting
Phase N/A
Start date October 31, 2023
Completion date August 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT00760734 - Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD) Phase 1
Withdrawn NCT02459145 - Assessing the Effects of a Clinical Exercise Protocol on Children With Post-concussion Syndrome N/A
Not yet recruiting NCT05848193 - mHealth Technology in the Treatment of Post-concussion Symptoms N/A
Completed NCT02266329 - Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin Phase 1/Phase 2
Completed NCT01962883 - Effects of Osteopathic Treatment on Vestibular Disturbed Active Post Concussed Individual N/A
Completed NCT02171312 - Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool N/A
Terminated NCT00871884 - Evaluation of Two Treatments for Chronic Post Concussion Syndrome Phase 1/Phase 2